Yan Orlov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Orlov has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aner Daum
Cardiology Department, Barzilai University Medical Center, Hahistadrout St 2, Ashkelon 30604, Israel
1 shared publication - Azriel Osherov
Department of Cardiology Barzilai Medical Center Ashkelon Israel
1 shared publication - Chaim Yosefy
Department of Cardiology, Barzilai University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Hahistadrut 2, Ashkelon, Israel
1 shared publication - Enrique Gallego-Colon
Department of Medicine, Escuela Militar de Sanidad, 28047 Madrid, Spain
1 shared publication - Jamal Jafari
Barzilai Medical Center, Ben-Gurion University of the Negev, Israel
1 shared publication - Jihad Abu Hamed
Cardiology Department, Barzilai University Medical Center, Hahistadrout St 2, Ashkelon 30604, Israel
1 shared publication
Latest Publications
- Open Access
- 7 October 2019
- Published by MDPI AG in Biomedicines
- Vol. 7 (4) , 79
Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
Coronary Artery Ectasia (CAE) is a phenomenon characterized by locally or diffuse coronary artery dilation of one or more coronary arteries. In the present study, the prevalence of acquired coronary ectasia and coronary risk factors for CAE was analyzed in patients undergoing cardiac catheterization for suspected ischemic heart disease. We retrospectively analyzed 4000 patients undergoing coronary angiography for suspected coronary artery disease at our cardiac catheterization unit, and a total of 171 patients were selected. The study group was divided into three groups, 65 patients with CAE, 62 patients with significant obstructive coronary artery disease, and 44 patients with normal coronary angiograms as a control group. A negative correlation was observed between high-density lipoprotein cholesterol (HDL-C) and the presence of CAE (r = −0.274, p < 0.001). In addition, HDL-C (OR, 0.858; CI, 0.749–0.984; p = 0.029), low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio (OR, 1.987; CI, 1.542–2.882; p = 0.034), and hemoglobin (OR, 2.060; CI, 1.114–3.809; p = 0.021) were identified as independent risk factors for the development of CAE. In fact, we observed that a one-unit increase in HDL-C corresponded to a 15% risk reduction in CAE development and that each unit increase in hemoglobin could potentially increase the CAE risk by 2-fold. Low HDL-C could significantly increase the risk of developing CAE in healthy individuals. Elevated hemoglobin could predispose to subsequent dilation and aneurysm of the coronary artery. This work suggests that disordered lipoprotein metabolism or altered hemoglobin values can predispose patients to aneurysmal coronary artery disease.
- 7 October 2019
- Published by MDPI AG in Biomedicines
- Vol. 7 (4) , 79
Open AccessLow High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
Coronary Artery Ectasia (CAE) is a phenomenon characterized by locally or diffuse coronary artery dilation of one or more coronary arteries. In the present study, the prevalence of acquired coronary ectasia and coronary risk factors for CAE was analyzed in patients undergoing cardiac catheterization for suspected ischemic heart disease. We retrospectively analyzed 4000 patients undergoing coronary angiography for suspected coronary artery disease at our cardiac catheterization unit, and a total of 171 patients were selected. The study group was divided into three groups, 65 patients with CAE, 62 patients with significant obstructive coronary artery disease, and 44 patients with normal coronary angiograms as a control group. A negative correlation was observed between high-density lipoprotein cholesterol (HDL-C) and the presence of CAE (r = −0.274, p < 0.001). In addition, HDL-C (OR, 0.858; CI, 0.749–0.984; p = 0.029), low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio (OR, 1.987; CI, 1.542–2.882; p = 0.034), and hemoglobin (OR, 2.060; CI, 1.114–3.809; p = 0.021) were identified as independent risk factors for the development of CAE. In fact, we observed that a one-unit increase in HDL-C corresponded to a 15% risk reduction in CAE development and that each unit increase in hemoglobin could potentially increase the CAE risk by 2-fold. Low HDL-C could significantly increase the risk of developing CAE in healthy individuals. Elevated hemoglobin could predispose to subsequent dilation and aneurysm of the coronary artery. This work suggests that disordered lipoprotein metabolism or altered hemoglobin values can predispose patients to aneurysmal coronary artery disease.